Paul Singer’s Elliott Investment Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund exited two positions ...

Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

One company to watch right now is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 15.28. This compares to its ...

Advanced Therapy Connect is a simplified ordering and reporting process for cell and gene therapy products, the company said. Inside Beauty spoke to Jamie Sachs, vice president, product marketing ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024 ... healthcare services driven by an aging population and advancements in medical technology. However, rising ...